Dates: Saturday 6th and Sunday 7th May, 2017. Venue: Lilliput Adventure Centre We are pleased to announce details of our first father & son(s) overnight, which will take place over the weekend of 6th & 7th May, 2017 in Lilliput Adventure Centre in Mullingar, Co. Westmeath. The overnight is open to fathers with …
Many thanks to everyone who attended our AGM & Conference 2017. We have uploaded photos from the weekend of our children\’s groups, adult sessions and Gala dinner. Click here to view photos.
Following a recent tender/procurement process undertaken by the Haemophilia Product Selection Board (which includes both haemophilia doctors and the Society), the recombinant factor IX coagulation factor concentrate used for the treatment of factor IX deficiency will be changed from Benefix to an Extended Half-Life factor IX concentrate called Alprolix for all people with factor …
Information Meetings – New Haemophilia B Treatment Read More »
Date: Saturday 13th May 2017 Venue: Castleknock Hotel, Castleknock, Dublin 15 This one‐day conference, (organised by the Irish Haemophilia Society) will be an opportunity for people with Hepatitis C, to receive updates on treatment, how to access treatment and what happens after treatment. THERE IS NO CHARGE TO ATTEND THIS CONFERENCE BUT REGISTRATION IS …
Here are some of the presentations from our AGM and Conference that took place over the weekend of the 3rd – 5th March, 2017. I.H.S. History: 1968 to 1982 AN UPDATE ON HAEMOPHILIA CARE VIETNAM: WHAT IS THE G.A.P PROGRAMME? – Dr. Nguyen Hoang Nam WFH GAP Vietnam Presentation – Mr. Alain Weill CARRIERS DISCUSSION …
Presentations from the I.H.S. AGM and Conference, 2017 Read More »
Gene Therapy The National Coagulation Centre (NCC) will be holding special clinics this month to offer blood tests to people with severe factor IX deficiency to assess their suitability for possible inclusion in a Gene Therapy clinical trial. Special clinics will be held on the mornings of Tuesday 21st March and Friday 24th March. Any …
Alprolix is the new extended half life treatment that will be available to haemophilia B patients in Ireland from April 2017. Alprolix will allow patients to infuse less frequently (typically once a week instead of twice a week.) Alprolix will also allow patients to maintain a higher trough level, meaning their factors levels won\’t …
The AGM & Conference takes place this coming weekend in the Slieve Russell Hotel in Co. Cavan. Many thanks to all of you who booked in to attend this conference. Confirmation letters went out to everyone who registered approximately 3 weeks ago. Registration will take place from 5.30pm to 8.00pm on Friday evening in the …
One of the new prospective treatments for people with haemophilia which are currently undergoing clinical trials is the bi-specific antibody called ‘Emicizumab’. This antibody treatment is designed to be a subcutaneously administered treatment which mimics the effect of factor VIII. It can be used to treat people with factor VIII deficiency or people with factor …
